Therefore, we measured fatty acid oxidation (FAO) driven oxygen consumption rate (OCR) and glycolytic rate (ECAR) in control (ScrKO) and Y5rKO cancer cells in the presence or absence of recombinant NPY treatment (100 nM). The gene discussed is NPY; the disease is cancer.